BioSpace News Archive

GLG Life Tech Corporation (TSX:GLG) (“GLG” or the “Company”), a global leader in the agricultural and commercial development of high-quality zero-calorie natural sweeteners, announces financial results for the three and twelve months ended December 31, 2023.

MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the “Company” or “MustGrow”), is pleased to announce the results of its 2024 annual meeting of shareholders (the “Meeting”) held on June 27, 2024.

A dispute between Daiichi Sankyo Co., Ltd. (TSE: 4568) and Seagen Inc. is now concluded and Seagen has paid Daiichi Sankyo approximately U.S. $47 million in connection with attorneys’ fees and costs plus interest awarded by the arbitrator of the party’s dispute.

Today, AllyGPO™, a new specialty Group Purchasing Organization (GPO) announced a partnership with IDEOlogy Health to provide multi-channel medical education to its oncology practice members.

Marking a milestone development in epigenetic research and clinical health applications, laboratory TruDiagnostic is launching the first ever, epigenetic aging analysis of individual organ systems, using validated and system-specific trained clocks.

ECRI, a global independent healthcare and patient safety nonprofit, names Clinica Imbanaco the winner of its 2024 Health Technology Excellence Award.

YorkTest has launched a new offer to make at-home food sensitivity and allergy testing more accessible to households across the US.

KBio, one of the leading developers of new biological treatments derived from a plant-based production system, today announced that the United States Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application for EV68-228-N, a human monoclonal IgG1 against the capsid of enterovirus D68 (EV-D68) designed as an intravenous therapeutic for the treatment of acute flaccid myelitis (AFM).